Skip to content
10-Q

Quarterly Report

Scotts Miracle-Gro Co SMG

0000825542-26-000024

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · May 1, 2026 58.18M sh
Shares Diluted Q2 2026 · Mar 28, 2026 59.1M sh
Shares Diluted Q2 2026 · Mar 28, 2026 59M sh
Shares Diluted Q2 2026 · Mar 29, 2025 58.4M sh
Shares Diluted Q2 2026 · Mar 29, 2025 58.6M sh
Stock Repurchased Q2 2026 · Mar 28, 2026 $11.6M
Stock Repurchased Q2 2026 · Mar 29, 2025 $18.3M
Dividends Paid Q2 2026 · Mar 28, 2026 $77.8M
Dividends Paid Q2 2026 · Mar 29, 2025 $78M
Capex Q2 2026 · Mar 28, 2026 $38.6M
Capex Q2 2026 · Mar 29, 2025 $37.6M
Operating Cash Flow Q2 2026 · Mar 28, 2026 −$150.4M
Operating Cash Flow Q2 2026 · Mar 29, 2025 −$257.2M
Long Term Debt Q2 2026 · Mar 28, 2026 $2.07B
Long Term Debt Q2 2026 · Sep 30, 2025 $2.05B
Long Term Debt Q2 2026 · Mar 29, 2025 $2.49B
Short Term Debt Q2 2026 · Mar 28, 2026 $279.4M
Short Term Debt Q2 2026 · Sep 30, 2025 $57.2M
Short Term Debt Q2 2026 · Mar 29, 2025 $54.6M
Cash And Equivalents Q2 2026 · Mar 28, 2026 $6.2M
Cash And Equivalents Q2 2026 · Sep 30, 2025 $32.8M
Cash And Equivalents restated Q2 2026 · Mar 29, 2025 $8.7M
Stockholders Equity Q2 2026 · Mar 28, 2026 −$286.5M
Stockholders Equity Q2 2026 · Dec 27, 2025 −$500.6M
Stockholders Equity Q2 2026 · Sep 30, 2025 −$357.5M
Stockholders Equity Q2 2026 · Mar 29, 2025 −$290.1M
Stockholders Equity Q2 2026 · Dec 28, 2024 −$479.5M
Stockholders Equity Q2 2026 · Sep 30, 2024 −$390.6M
Current Liabilities Q2 2026 · Mar 28, 2026 $1.28B
Current Liabilities Q2 2026 · Sep 30, 2025 $739.7M
Current Liabilities Q2 2026 · Mar 29, 2025 $1.01B
Total Liabilities Q2 2026 · Mar 28, 2026 $3.7B
Total Liabilities Q2 2026 · Sep 30, 2025 $3.1B
Total Liabilities Q2 2026 · Mar 29, 2025 $3.83B
Current Assets Q2 2026 · Mar 28, 2026 $1.62B
Current Assets Q2 2026 · Sep 30, 2025 $940.3M
Current Assets Q2 2026 · Mar 29, 2025 $1.73B
Total Assets Q2 2026 · Mar 28, 2026 $3.41B
Total Assets Q2 2026 · Sep 30, 2025 $2.74B
Total Assets Q2 2026 · Mar 29, 2025 $3.54B
Eps Diluted Q2 2026 · Mar 28, 2026 $4.04
Eps Diluted Q2 2026 · Mar 28, 2026 $1.93
Eps Diluted Q2 2026 · Mar 29, 2025 $3.72
Eps Diluted Q2 2026 · Mar 29, 2025 $2.53
Eps Basic Q2 2026 · Mar 28, 2026 $4.11
Eps Basic Q2 2026 · Mar 28, 2026 $1.96
Eps Basic Q2 2026 · Mar 29, 2025 $3.78
Eps Basic Q2 2026 · Mar 29, 2025 $2.57
Sga Expense Q2 2026 · Mar 28, 2026 $199.2M
Sga Expense Q2 2026 · Mar 28, 2026 $305.1M
Sga Expense restated Q2 2026 · Mar 29, 2025 $177.8M
Sga Expense restated Q2 2026 · Mar 29, 2025 $291.3M
Net Income Q2 2026 · Mar 28, 2026 $238.6M
Net Income Q2 2026 · Mar 28, 2026 $113.6M
Net Income Q2 2026 · Mar 29, 2025 $217.5M
Net Income Q2 2026 · Mar 29, 2025 $148M
Operating Income Q2 2026 · Mar 28, 2026 $401.8M
Operating Income Q2 2026 · Mar 28, 2026 $380M
Operating Income restated Q2 2026 · Mar 29, 2025 $349.7M
Operating Income restated Q2 2026 · Mar 29, 2025 $303.9M
Gross Profit Q2 2026 · Mar 28, 2026 $610.5M
Gross Profit Q2 2026 · Mar 28, 2026 $699.2M
Gross Profit restated Q2 2026 · Mar 29, 2025 $542.1M
Gross Profit restated Q2 2026 · Mar 29, 2025 $630.6M
Cost Of Revenue Q2 2026 · Mar 28, 2026 $849M
Cost Of Revenue Q2 2026 · Mar 28, 2026 $1.11B
Cost Of Revenue restated Q2 2026 · Mar 29, 2025 $842.3M
Cost Of Revenue restated Q2 2026 · Mar 29, 2025 $1.12B
Revenue Q2 2026 · Mar 28, 2026 $1.46B
Revenue Q2 2026 · Mar 28, 2026 $1.81B
Revenue restated Q2 2026 · Mar 29, 2025 $1.39B
Revenue restated Q2 2026 · Mar 29, 2025 $1.76B